Asher Bio
We build better immunotherapies
San Carlos, United States · Founded 2019 · $218.2M raised
- Headquarters
- San Carlos, California
- Employees
- 1–10
- Founded
- 2019
- Website
- asherbio.com
- Total Funding
- $218.2M
- Last Round
- $55.0M Series CApr 2024
- Rounds
- 4
About
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
Summary
Asher Bio is a Biotech company based in San Carlos, United States, founded in 2019. It has raised $218.2M in total across 4 rounds, most recently a $55.0M Series C round in Apr 2024. Investors include RA Capital Management, Wellington Management and Third Rock Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.